Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
7 studies found for:    20530316 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Dose Escalation Versus Standard in Laryngopharyngeal Cancers
Conditions: Malignant Neoplasm of Oropharynx Stage III;   Malignant Neoplasm of Larynx Stage III;   Malignant Neoplasm of Hypopharynx Stage III;   Malignant Neoplasm of Oropharynx Stage IVa;   Malignant Neoplasm of Oropharynx Stage IVb;   Malignant Neoplasm of Larynx Stage IV;   Malignant Neoplasm of Hypopharynx Stage IVa;   Malignant Neoplasm of Hypopharynx Stage IVb
Interventions: Radiation: Escalated Dose;   Radiation: Standard Dose
2 Recruiting TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
Condition: Non-HPV Locally Advanced Head and Neck Cancer
Interventions: Radiation: Intensity Modulated Radiation Therapy (IMRT);   Drug: Cisplatin;   Drug: placebo;   Drug: Lapatinib
3 Recruiting The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Condition: Squamous Cell Carcinomas
Interventions: Radiation: Reduced Dose Radiation;   Radiation: Standard Dose Radiation
4 Active, not recruiting De-intensification of Radiation and Chemotherapy for Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma
Conditions: Carcinoma, Squamous Cell;   Head and Neck Neoplasms;   Oropharyngeal Neoplasms
Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT);   Drug: Cisplatin;   Procedure: Limited surgical evaluation
5 Completed Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Cabazitaxel 15mg/m2;   Drug: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
6 Completed Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Conditions: Head and Neck Cancer;   Oropharyngeal Cancer;   Human Papillomavirus;   Squamous Cell Cancer
Intervention:
7 Active, not recruiting
Has Results
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: cisplatin;   Radiation: Standard fractionation RT;   Radiation: Accelerated fractionation radiation therapy;   Procedure: Conventional surgery for select patients

Indicates status has not been verified in more than two years